209 related articles for article (PubMed ID: 33996266)
21. Intratumoral PD-1
Yu K; Gu Y; Zhang P; Fang H; Cao Y; Wang J; Lin C; Liu H; Zhang H; He H; Li R; Qin J; Li H; Xu J
Br J Cancer; 2022 Nov; 127(9):1709-1717. PubMed ID: 36002752
[TBL] [Abstract][Full Text] [Related]
22. Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer.
Xia S; Gu Y; Zhang H; Fei Y; Cao Y; Fang H; Wang J; Lin C; Zhang H; Li H; He H; Xu J; Li R; Liu H; Zhang W
Oncoimmunology; 2021; 10(1):1975386. PubMed ID: 34552824
[TBL] [Abstract][Full Text] [Related]
23. Poor clinical outcomes and immunoevasive contexture in CD161
Chen Q; Yin H; Jiang Z; He T; Xie Y; Mao W; Han J; Liu S; Lou W; Wu W; Habib JR; Yu J; Liu L; Pu N
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38531664
[TBL] [Abstract][Full Text] [Related]
24. Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer.
Xu C; Fang H; Gu Y; Yu K; Wang J; Lin C; Zhang H; Li H; He H; Liu H; Li R
Cancer Sci; 2022 Dec; 113(12):4070-4081. PubMed ID: 35997524
[TBL] [Abstract][Full Text] [Related]
25. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.
Shen Z; Zhou S; Wang Y; Li RL; Zhong C; Liang C; Sun Y
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1585-95. PubMed ID: 20221835
[TBL] [Abstract][Full Text] [Related]
26. Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Qi Y; Chang Y; Wang Z; Chen L; Kong Y; Zhang P; Liu Z; Zhou Q; Chen Y; Wang J; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang Y; Xu J; Zhang W
Cancer Immunol Immunother; 2019 Dec; 68(12):2067-2080. PubMed ID: 31720813
[TBL] [Abstract][Full Text] [Related]
27. Stromal LAG-3
Zeng H; Zhou Q; Wang Z; Zhang H; Liu Z; Huang Q; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Xu L; Dai B; Guo J; Liu L; Zhu Y; Xu J
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32540859
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103
Li R; Liu H; Cao Y; Wang J; Chen Y; Qi Y; Lv K; Liu X; Yu K; Lin C; Zhang H; He H; Li H; Chen L; Shen Z; Qin J; Zhang W; Sun Y; Xu J
Br J Cancer; 2020 May; 122(10):1525-1534. PubMed ID: 32205862
[TBL] [Abstract][Full Text] [Related]
29. Tumor-infiltrating CD226
Zhang Y; Zhao ZX; Gao JP; Huang YK; Huang H
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4381-4389. PubMed ID: 36107244
[TBL] [Abstract][Full Text] [Related]
30. Distribution of circulating follicular helper T cells and expression of interleukin-21 and chemokine C-X-C ligand 13 in gastric cancer.
Meng X; Yu X; Dong Q; Xu X; Li J; Xu Q; Ma J; Zhou C
Oncol Lett; 2018 Sep; 16(3):3917-3922. PubMed ID: 30128008
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.
Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH
Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841
[TBL] [Abstract][Full Text] [Related]
32. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients.
Lv K; Li R; Cao Y; Gu Y; Liu X; He X; Jin K; Fang H; Fei Y; Shi M; Liu H; Li H; He H; Lin C; Zhang H; Xu J
Int J Cancer; 2021 Feb; 148(3):759-768. PubMed ID: 33105024
[TBL] [Abstract][Full Text] [Related]
34. Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival.
Vlaming M; Bilemjian V; Freile JÁ; Melo V; Plat A; Huls G; Nijman HW; de Bruyn M; Bremer E
Front Immunol; 2022; 13():1031746. PubMed ID: 36341460
[TBL] [Abstract][Full Text] [Related]
35. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
36. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
37. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer.
Zhang P; Gu Y; Fang H; Cao Y; Wang J; Liu H; Zhang H; Li H; He H; Li R; Lin C; Xu J
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35110359
[TBL] [Abstract][Full Text] [Related]
39. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta.
O'Connor RA; Martinez BR; Koppensteiner L; Mathieson L; Akram AR
Front Immunol; 2023; 14():1221532. PubMed ID: 37520560
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]